| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/02/1997 | EP0621871B1 A human kunitz-type protease inhibitor variant |
| 07/02/1997 | EP0575350A4 Method for culturing and transforming human stem cell-containing compositions |
| 07/02/1997 | EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 07/02/1997 | CN1153555A Oligomer carrier molecules in which marker groups and haptens are selectively incorporated |
| 07/02/1997 | CN1153530A Rheumatoid arthritis-related virus MSRV-1 and pathogenic and/or infective agent MSRV-2 |
| 07/02/1997 | CN1153529A Hepatitis G virus and molecular cloning thereof |
| 07/02/1997 | CN1153528A Pantropic neurotrophic factors |
| 07/01/1997 | USH1662 Chemically modified lymphokine and production thereof |
| 07/01/1997 | US5644065 Having somataic and germ cells containing an inserted exogenous dna sequence which prevents gene expression of major histocompatibility complex |
| 07/01/1997 | US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 07/01/1997 | US5644046 Cloning of a gene encoding for the growth hormone releasing hormone receptor |
| 07/01/1997 | US5644045 X-linked adrenoleukodystrophy gene and corresponding protein |
| 07/01/1997 | US5644036 Purified immunoglobulin |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment |
| 07/01/1997 | US5644032 Process for producing fibrinogen concentrates |
| 07/01/1997 | US5644031 Delta-like gene expressed in neuroendocrine tumors |
| 07/01/1997 | US5644030 Gene and method for production of an IgA binding protein |
| 07/01/1997 | US5644026 Antitumor agent polypeptides |
| 07/01/1997 | US5643924 Retroviral protease inhibitors |
| 07/01/1997 | US5643881 Protein having anti-HIV activity and method for obtaining it |
| 07/01/1997 | US5643880 Casein isolated from milk and joining to oropharyngeal cells |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 07/01/1997 | US5643876 Biologically active synthetic magainin peptides |
| 07/01/1997 | US5643875 Proteins and endotoxins |
| 07/01/1997 | US5643873 Antiinflammatory |
| 07/01/1997 | US5643872 Antiagglomerants for platelets, anticoagulants |
| 07/01/1997 | US5643871 Antitumor antibiotics |
| 07/01/1997 | US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
| 07/01/1997 | US5643792 Mutant strain of Pichia pastoris which utilizes methanol in the presence of glucose |
| 07/01/1997 | US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors |
| 07/01/1997 | US5643783 Collagen and uses therefor |
| 07/01/1997 | US5643782 Immortalized epithelial cell lines |
| 07/01/1997 | US5643781 DNA encoding protocadherin-42 |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643774 Dna molecules with polypeptides formed by biosynthesis |
| 07/01/1997 | US5643772 Cryptosporidium hybrid vector and transformed host cells |
| 07/01/1997 | US5643771 Non-reverting live bacterial vaccines |
| 07/01/1997 | US5643761 Cells with dna, releasing, denaturing and hybridizing dna inserts |
| 07/01/1997 | US5643757 High yield production of human apolipoprotein A1 in E. coli. |
| 07/01/1997 | US5643756 Fusion glycoproteins |
| 07/01/1997 | US5643755 Wound healing, antiischemic, blocking blood vessel growth |
| 07/01/1997 | US5643754 Nucleic acids encoding a leptospira outer membrane protein |
| 07/01/1997 | US5643753 Use of autologous promoters to express gene products in bordetella |
| 07/01/1997 | US5643752 Culture of cells to produce polypeptides |
| 07/01/1997 | US5643751 Borrelia burgdorferi antigens and uses thereof |
| 07/01/1997 | US5643750 Human neuronal beta subunits of voltage-operated calcium channels and the use thereof |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643747 Gene expression and cloning of bordetella genome and dna sequences |
| 07/01/1997 | US5643745 Heterologous dimeric proteins produced in heterokaryons |
| 07/01/1997 | US5643740 Diagnostic and therapeutic uses in cancer, autoimmune disease and transplant rejection |
| 07/01/1997 | US5643737 Merozoite proteins for use in detection of Babesia equi in horses using immunological techniques |
| 07/01/1997 | US5643734 Kits for qualitative and quantitative analysis |
| 07/01/1997 | US5643733 Lyme disease assay |
| 07/01/1997 | US5643729 Methods for diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by detecting an acceleration of exon skipping in IRF-1 mRNA |
| 07/01/1997 | US5643727 BCL-2 gene inhibitory element binding factor |
| 07/01/1997 | US5643726 Integral membrane glycoproteins, genes and promoters |
| 07/01/1997 | US5643725 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable haemophilus influenzae |
| 07/01/1997 | US5643724 Methods and reagents for Glycophorin A typing |
| 07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
| 07/01/1997 | US5643715 Human papillomavirus type 52 DNA sequences and methods for employing the same |
| 07/01/1997 | US5643714 Method and assay for HTLV |
| 07/01/1997 | US5643579 Producing antibodies or cell mediated immunity to adenovirus |
| 07/01/1997 | US5643578 Subunit vaccines |
| 07/01/1997 | US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen |
| 07/01/1997 | US5643575 Non-antigenic branched polymer conjugates |
| 07/01/1997 | US5643572 Monoclonal antibody to urushiol |
| 07/01/1997 | US5643570 BPI-immunoglobulin fusion proteins |
| 07/01/1997 | US5643567 Antigrowth agents for tumors |
| 07/01/1997 | US5643566 Formulation processes for lipophilic proteins |
| 07/01/1997 | US5643564 Glycosylated cytokines |
| 07/01/1997 | US5643563 N-∇3 deletion mutants of the short form of CSF-1 |
| 07/01/1997 | US5643464 Process for preparing a sterile, dry crosslinking agent |
| 06/26/1997 | WO1997022972A2 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule |
| 06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | WO1997022708A1 Primate cluster-forming embryonic hematopoietic stem cells |
| 06/26/1997 | WO1997022706A1 Vector for expression of n-terminally extended proteins in yeast cell |
| 06/26/1997 | WO1997022705A1 A FUNGUNS WHEREIN THE areA, pepC AND/OR pepE GENES HAVE BEEN INACTIVATED |
| 06/26/1997 | WO1997022701A1 Equine rhinovirus 1 proteins |
| 06/26/1997 | WO1997022700A2 Grapevine leafroll virus proteins and their uses |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022696A1 Utrophin gene expression |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022694A2 Diagnostic reagents relating to diabetes |
| 06/26/1997 | WO1997022689A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/26/1997 | WO1997022626A1 Ldti crystals |
| 06/26/1997 | WO1997022625A1 Ghrh-rp compositions and methods |
| 06/26/1997 | WO1997022624A2 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 06/26/1997 | WO1997022623A1 Osteo antiviral protein |
| 06/26/1997 | WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 06/26/1997 | WO1997022617A1 Methods for identifying compounds that bind to a target |
| 06/26/1997 | WO1997022363A2 Improved pharmaceutical compositions |
| 06/26/1997 | WO1997022255A1 p62 POLYPEPTIDES, RELATED POLYPEPTIDES, AND USES THEREFOR |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997020045A3 P2u2 purinergic receptor |
| 06/26/1997 | WO1997011190A3 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 06/26/1997 | WO1997007225A3 High efficiency retroviral packaging system |